2022, Number 1
<< Back Next >>
Med Crit 2022; 36 (1)
Risk factors for acute kidney injury and renal replacement therapy in severe critically ill patients with COVID-19 under invasive mechanical ventilation
Chávez RLI, Rodríguez ZC, Sánchez CA, Chaires GR, Aguirre SJS
Language: Spanish
References: 39
Page: 22-30
PDF size: 275.45 Kb.
ABSTRACT
Introduction: Since December 2019, when respiratory coronavirus type 2 and acute respiratory failure syndrome (ARDS) due to coronavirus type 2 (coronavirus disease 2019 [COVID-19]), developed in Wuhan, China, it has become a global pandemic, with 105,333,798 cases reported on February 4, 2021. On February 27, 2020, Mexico City reported the first case of COVID-19, followed by a massive growth of infections across the country. The total number of cases today is 1,886,245 with 81,223 estimated active cases. 18.77% of patients have required hospitalization. The total number of deaths is 164,290 with an estimated 184,125. AKI was found in 28% of hospitalized patients and 46% of critically ill patients, contributing to significantly higher mortality. Identification of risk factors is important to guide early decision making in triaging patients for more intensive monitoring and prevent increased mortality.
Objective: To analyze the level of PEEP and inflammatory factors involved in the development of AKI and onset of RRT in patients with COVID-19.
Material and methods: An observational, cross-sectional and retrolective study was performed in mechanically ventilated patients with SARS-CoV-2 who presented AKI and need for RRT admitted to the respiratory intensive care unit of the ABC Medical Center. Statistical analysis of measures of central tendency, descriptive; for the identification of the variable with the greatest impact for the development of AKI and dialytic therapy, a positive predictive factor was performed, Pearson test to correlate with renal replacement therapy. The study was approved by the ethics committee of the ABC Medical Center, Mexico City (Number: ABC TAEABC-22-117).
Results: A total of 210 mechanically ventilated patients with SARS-CoV-2 in the Respiratory Intensive Care Unit of the ABC Medical Center were analyzed, of whom 51 patients (24.17%) developed AKI and 21 patients required RRT. An ROC curve was performed to predict the factor with the highest risk of developing AKI, finding significant differences in IL-6 with an area under the ROC curve of 0.909 (CI: 0.86-0.95). Statistical significance was found in AKI with PEEP above 13cmH
2O and renal replacement therapy with PEEP > 15cmH
2O.
Conclusion: A correlation was found between high PEEP levels and acute kidney injury. Inflammatory markers at patient admission (specifically IL-6) are adequate parameters to guide treatment; however, they are also useful to guide prognosis.
REFERENCES
Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708-1720.
World Health Organization. Novel coronavirus-China. January 2020. [Accessed February 02, 2020] Available at: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200121-sitrep-1-2019-ncov.pdf
COVID-19 Dashboard by the Center for Systems Science and Engineering at Johns Hopkins University. [Accessed February 04, 2020] Available at: https://coronavirus.jhu.edu/map.html
Suárez V, Suarez QM, Oros RS, Ronquillo DJE. Epidemiology of COVID-19 in Mexico: from the 27th of February to the 30th of April 2020. Revista Clínica Española. 2020;220(8):463-471. https://doi.org/10.1016/j.rce.2020.05.007
https://news.google.com/covid19/map?hl=es-419&gl=MX&ceid=MX%3Aes-419&mid=%2Fm%2F0b90_r [Consultado el 28 Junio 21]
https://datos.covid-19.conacyt.mx/ [Consultado el 28 Junio 21]
Lynch MR, Tang J. COVID-19 and kidney injury. R I Med J. 2020;103(8):24-28.
Navas-Blanco JR, Dudaryk R. Management of Respiratory Distress Syndrome due to COVID-19 infection. BMC Anesthesiol. 2020;20:177. Available in: https://doi.org/10.1186/s12871-020-01095-7
Mohlenkamp S, Thiele H. Ventilation of COVID-19 patients in intensive care units. Herz 2020;45:329-331. Available in: https://doi.org/10.1007/s00059-020-04923-1
Richardson S, Hirsch JS, Narasimhan M et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with Covid-19 in the New York city area. JAMA. 2020;323(20):2052-2059. Available in: https://doi.org/10.1001/jama.2020.6775
Cheng Y, Luo R, Wang K, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97(5):829-838. Available in: https://doi.org/10.1016/j.kint.2020.03.005
Gupta S, Hayek SS, Wang W, et al. Factors associated with death in critically ill patients with coronavirus disease 2019 in the US. JAMA Intern Med. 2020:180(11):1436-1447. Available in: https://doi.org/10.1001/jamainternmed.2020.3596
Baduashvili A, Oberle LP, Devitt J. Frequency of continuous renal replacement therapy use early in coronavirus disease 2019 pandemic. Crit Care Explor. 2020;2(5):e0129.
Bhatraju PK, Ghassemieh BJ, Nichols M, et al. Covid-19 in critically ill patients in the Seattle region-case series. N Engl J Med. 2020;382:2012-2022.
CDC COVID-19 Response Team. Severe outcomes among patients with coronavirus disease 2019 (COVID-19)-United States. February 12-March 16, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:343-346.
Hirsch JS, Ng JH, Ross DW, et al. Acute kidney injury in patients hospitalized with COVID-19. Kidney Int. 2020;98(1):209-218. doi: 10.1016/j.kint.2020.05.006.
Chan L, Chaudhary K, Saha A, et al. Acute Kidney Injury in Hospitalized Patients with COVID-19. medRxiv. 2020 May 8;2020.05.04.20090944. doi: 10.1101/2020.05.04.20090944.
Mohamed MMB, Lukitsch I, Torres-Ortiz AE et al. Acute kidney injury associated with coronavirus disease 2019 in urban New Orleans. Kidney360. 2020;1(7):614-622. Available in: https://doi.org/10.34067/
Pei G, Zhang Z, Peng J, et al. Renal involvement and early prognosis in patients with Covid-19 pneumonia. JASN. 2020;31(6):1157-1165. Available in: https://doi.org/10.1681/ASN.2020030276
Kellum JA, Nadim MK, Forni LG. Sepsis-associated acute kidney injury: is Covid-19 different? Kidney Int. 2020;98(6):P1370-1372. Available in: https://doi.org/10.1016/j.kint.2020.08.009
Kudose S, Batal I, Santoriello D, et al. kidney biopsy findings in patients with COVID-19. J Am Soc Nephrol. 2020. doi: 10.1681/ASN.2020060802.
Wu H, Larsen CP, Hernandez-Arroyo CF, et al. AKI and collapsing glomerulopathy associated with COVID-19 and APOL1 high-risk genotype. J Am Soc Nephrol. 2020;31(8):1688-1695. doi: 10.1681/ASN.2020050558.
Huang C, Wang Y, Li X, et al. Clinical features of patients in- fected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5.
Ruan Q, Yang K, Wang W, et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46(5):846-848. doi: 10.1007/s00134-020-05991-x.
Escher R, Breakey N, Lammle B. Severe COVID-19 infection associated with endothelial activation. Thromb Res. 2020;190:62. doi: 10.1016/j.thromres.2020.04.014.
Pan X-W, Xu D, Zhang H, et al. Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis. Intensive Care Med. 2020;46(6):1114-1116. doi: 10.1007/s00134-020-06026-1.
Polidoro RB, Hagan RS, de Santis Santiago R, et al. Overview: systemic inflammatory response derived from lung injury caused by SARS-CoV-2 Infection Explains Severe Outcomes in COVID-19. Front Immunol. 2020;11:1626. doi: 10.3389/fimmu.2020.01626.
Panitchote A, Mehkri O, Hastings A, et al. Factors associated with acute kidney injury in acute respiratory distress syndrome. Ann Intensive Care. 2019;9(1):74. doi: 10.1186/s13613-019-0552-5.
Meade MO, Cook DJ, Guyatt GH, et al. Lung open ventilation study investigators: ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA. 2008;299:637-645.
Gabarre P, Dumas G, Dupont T. Acute kidney injury in critically ill patients with COVID-19. Intensive Care Med. 2020;12:1-10. doi: 10.1007/s00134-020-06153-9.
Annat G, Viale JP, Xuan BB. Effect of PEEP ventilation on renal function, plasma renin, aldosterone, neurophysins and urinary ADH, and prostaglandins. Anesthesiology. 1983;58:136-141. doi: 10.1097/00000542-198302000-00006.
Husain-Syed F, Slutsky AS, Ronco C. Lung-kidney cross-talk in the critically ill patient. Am J Respir Crit Care Med. 2016;194(4):402-414. doi: 10.1164/rccm.201602-0420CP.
Gabarre P, Dumas G, Dupont T, et al. Acute kidney injury in critically ill patients with COVID-19. Intensive Care Med. 2020;46(7):1339-1348. doi: 10.1007/s00134-020-06153-9.
Van den Akker JP, Egal M, Groeneveld AB. Invasive mechanical ventilation as a risk factor for acute kidney injury in the critically ill: a systematic review and meta-analysis. Crit Care. 2013;17(3):R98. doi: 10.1186/cc12743.
Mercat A, Richard JC, Vielle B, et al. Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA. 2008;299(6):646-655.
Darmon M, Clec'h C, Adrie C, et al. Acute respiratory distress syndrome and risk of AKI among critically ill patients. Clin J Am Soc Nephrol. 2014;9(8):1347-1353. doi: 10.2215/CJN.08300813.
Beurton A, Haudebourg L, Simon-Tillaux N, Demoule A, Dres M. Limiting positive end-expiratory pressure to protect renal function in SARS-CoV-2 critically ill patients. J Crit Care. 2020;59:191-193. doi: 10.1016/j.jcrc.2020.07.008.
Sharkey RA, Mulloy EM, Long M, et al. The effect of continuous positive airway pressure (CPAP) on renal vascular resistance: the influence of renal denervation. Crit Care, 1999;3(33). Available in: https://doi.org/10.1186/cc304
Lumlertgul N, Pirondini L, Cooney E, et al. Acute kidney injury prevalence, progression and long-term outcomes in critically ill patients with COVID-19: a cohort study. Ann Intensive Care. 2021;11:123 Available in: https://doi.org/10.1186/s13613-021-00914-5